Home Antibody All anti-TNFRSF12A antibodies
Also for TNFRSF12A (NM_016639)
|Fn14 antibody was raised against a human IgG1 Fc-tagged Fn14 protein.|
||WB: 1 ug/ml
|PBS containing 0.02% sodium azide.|
|Affinity chromatography purified via peptide column
|Homo sapiens tumor necrosis factor receptor superfamily, member 12A (TNFRSF12A)|
|CD266; FN14; TWEAKR|
|TWEAK is a TNF family member produced by IFN-gamma-stimulated monocytes and induces multiple cell death pathways including caspase-dependent apoptosis and cathepsin B-dependent necrosis. These pathways are mediated by the binding of TWEAK by fibroblast growth factor 14 (Fn14), a member of the TNF receptor superfamily. Yeast two-hybrid experiments have shown that FN14 will bind to the TNFR-associated factors TRAF1, TRAF2, TRAF3, and TRAF5, suggesting that the signaling pathway induced by TWEAK may be mediated by one or more of these adaptor molecules. Fn14 is induced during liver regeneration and is highly expressed in hepatocellular carcinomas. In addition, TWEAK induces liver progenitor cell proliferation, suggesting Fn14 may play a role in hepatocyte growth control and liver neoplasia.|
Cytokine-cytokine receptor interaction
* Availability is in business days
* OriGene provides validated application data and protocol, with money back guarantee.
Western blot analysis of Fn14 in (A) mock- and (B) Fn14-GPI-transfected 293 cells with Fn14 antibody at 1 ug/ml.
Immunohistochemistry of Fn14 in human liver tissue with Fn14 antibody at 2.5 ug/ml.